{"id":2944,"date":"2025-08-04T07:00:00","date_gmt":"2025-08-04T07:00:00","guid":{"rendered":"https:\/\/imagenglobal.org.mx\/?p=2944"},"modified":"2025-08-05T04:26:54","modified_gmt":"2025-08-05T04:26:54","slug":"persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab","status":"publish","type":"post","link":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/","title":{"rendered":"Persistencia m\u00e1s progresi\u00f3n locorregional de la enfermedad a c\u00fapula y ganglios il\u00edacos, una posible alternativa a la exenteraci\u00f3n p\u00e9lvica con el uso de pembrolizumab"},"content":{"rendered":"\n<p><strong>Residente de Ginecolog\u00eda y Obstetricia: Isa\u00edas Ram\u00edrez D\u00e1vila, Ginec\u00f3logo Onc\u00f3logo: Jose Miguel Reyes Garita<\/strong><\/p>\n\n\n\n<p><strong>Reporte de caso<\/strong><\/p>\n\n\n\n<p>-Paciente de 35 a\u00f1os.<\/p>\n\n\n\n<p>-Sin antecedentes heredo familiares oncolog\u00edcos.<\/p>\n\n\n\n<p>-Niega cormobilidades.<\/p>\n\n\n\n<p>-Antecedentes Gineco Obst\u00e9tricos.<\/p>\n\n\n\n<p>-IVSA: 18 a\u00f1os.<\/p>\n\n\n\n<p>-NPS: 1<\/p>\n\n\n\n<p>-PARA: 21011<\/p>\n\n\n\n<p>-CCV OCT 2023 NEGATIVA.<\/p>\n\n\n\n<p><strong>Exploraci\u00f3n f\u00edsica<\/strong><\/p>\n\n\n\n<p>Abdomen blando, depresible, no doloroso, sin datos de irritaci\u00f3n peritoneal, vulva y vagina sin alteraciones aparentes, a la especuloscop\u00eda, se observa tumor dependiente de c\u00e9rvix de aproximadamente 6 cm, param\u00e9trio derecho tomado, izquierdo negativo.<\/p>\n\n\n\n<p>Noviembre del 2023, refiere dolor p\u00e9lvico, secreci\u00f3n transvaginal ligeramente f\u00e9tida. Se solicita TAC. Se realiza toma de biopsia de cuello uterino con reporte de Carcinoma escamoso invasor no queratizante, moderadamente diferenciado.<\/p>\n\n\n\n<p>Te invitamos a continuar con la lectura en la<a href=\"https:\/\/imagenglobal.org.mx\/wp-content\/uploads\/2025\/07\/Revista-COMEGOM.pdf\">\u00a0p\u00e1gina 37 de Memorias de COMEGOM.<\/a><\/p>\n\n\n\n<p><\/p>\n<div class=\"pvc_clear\"><\/div><p id=\"pvc_stats_2944\" class=\"pvc_stats total_only  \" data-element-id=\"2944\" style=\"\"><i class=\"pvc-stats-icon small\" aria-hidden=\"true\"><svg aria-hidden=\"true\" focusable=\"false\" data-prefix=\"far\" data-icon=\"chart-bar\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 512 512\" class=\"svg-inline--fa fa-chart-bar fa-w-16 fa-2x\"><path fill=\"currentColor\" d=\"M396.8 352h22.4c6.4 0 12.8-6.4 12.8-12.8V108.8c0-6.4-6.4-12.8-12.8-12.8h-22.4c-6.4 0-12.8 6.4-12.8 12.8v230.4c0 6.4 6.4 12.8 12.8 12.8zm-192 0h22.4c6.4 0 12.8-6.4 12.8-12.8V140.8c0-6.4-6.4-12.8-12.8-12.8h-22.4c-6.4 0-12.8 6.4-12.8 12.8v198.4c0 6.4 6.4 12.8 12.8 12.8zm96 0h22.4c6.4 0 12.8-6.4 12.8-12.8V204.8c0-6.4-6.4-12.8-12.8-12.8h-22.4c-6.4 0-12.8 6.4-12.8 12.8v134.4c0 6.4 6.4 12.8 12.8 12.8zM496 400H48V80c0-8.84-7.16-16-16-16H16C7.16 64 0 71.16 0 80v336c0 17.67 14.33 32 32 32h464c8.84 0 16-7.16 16-16v-16c0-8.84-7.16-16-16-16zm-387.2-48h22.4c6.4 0 12.8-6.4 12.8-12.8v-70.4c0-6.4-6.4-12.8-12.8-12.8h-22.4c-6.4 0-12.8 6.4-12.8 12.8v70.4c0 6.4 6.4 12.8 12.8 12.8z\" class=\"\"><\/path><\/svg><\/i> <img decoding=\"async\" width=\"16\" height=\"16\" alt=\"Loading\" src=\"https:\/\/imagenglobal.org.mx\/wp-content\/plugins\/page-views-count\/ajax-loader-2x.gif\" border=0 \/><\/p><div class=\"pvc_clear\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Residente de Ginecolog\u00eda y Obstetricia: Isa\u00edas Ram\u00edrez D\u00e1vila, Ginec\u00f3logo Onc\u00f3logo: Jose Miguel Reyes Garita Reporte de caso -Paciente de 35 a\u00f1os. -Sin antecedentes heredo familiares oncolog\u00edcos. -Niega cormobilidades. -Antecedentes Gineco Obst\u00e9tricos. -IVSA: 18 a\u00f1os. -NPS: 1 -PARA: 21011 -CCV OCT 2023 NEGATIVA. Exploraci\u00f3n f\u00edsica Abdomen blando, depresible, no doloroso, sin datos de irritaci\u00f3n peritoneal, vulva&hellip; <br \/> <a class=\"read-more\" href=\"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/\">Leer m\u00e1s<\/a><\/p>\n<div class=\"pvc_clear\"><\/div>\n<p id=\"pvc_stats_2944\" class=\"pvc_stats total_only  \" data-element-id=\"2944\" style=\"\"><i class=\"pvc-stats-icon small\" aria-hidden=\"true\"><svg aria-hidden=\"true\" focusable=\"false\" data-prefix=\"far\" data-icon=\"chart-bar\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 512 512\" class=\"svg-inline--fa fa-chart-bar fa-w-16 fa-2x\"><path fill=\"currentColor\" d=\"M396.8 352h22.4c6.4 0 12.8-6.4 12.8-12.8V108.8c0-6.4-6.4-12.8-12.8-12.8h-22.4c-6.4 0-12.8 6.4-12.8 12.8v230.4c0 6.4 6.4 12.8 12.8 12.8zm-192 0h22.4c6.4 0 12.8-6.4 12.8-12.8V140.8c0-6.4-6.4-12.8-12.8-12.8h-22.4c-6.4 0-12.8 6.4-12.8 12.8v198.4c0 6.4 6.4 12.8 12.8 12.8zm96 0h22.4c6.4 0 12.8-6.4 12.8-12.8V204.8c0-6.4-6.4-12.8-12.8-12.8h-22.4c-6.4 0-12.8 6.4-12.8 12.8v134.4c0 6.4 6.4 12.8 12.8 12.8zM496 400H48V80c0-8.84-7.16-16-16-16H16C7.16 64 0 71.16 0 80v336c0 17.67 14.33 32 32 32h464c8.84 0 16-7.16 16-16v-16c0-8.84-7.16-16-16-16zm-387.2-48h22.4c6.4 0 12.8-6.4 12.8-12.8v-70.4c0-6.4-6.4-12.8-12.8-12.8h-22.4c-6.4 0-12.8 6.4-12.8 12.8v70.4c0 6.4 6.4 12.8 12.8 12.8z\" class=\"\"><\/path><\/svg><\/i> <img decoding=\"async\" width=\"16\" height=\"16\" alt=\"Loading\" src=\"https:\/\/imagenglobal.org.mx\/wp-content\/plugins\/page-views-count\/ajax-loader-2x.gif\" border=0 \/><\/p>\n<div class=\"pvc_clear\"><\/div>\n","protected":false},"author":1,"featured_media":2946,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[25,34],"class_list":["post-2944","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articulos","tag-comegom","tag-exenteracion-pelvica"],"a3_pvc":{"activated":true,"total_views":37,"today_views":0},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Persistencia m\u00e1s progresi\u00f3n locorregional de la enfermedad a c\u00fapula y ganglios il\u00edacos, una posible alternativa a la exenteraci\u00f3n p\u00e9lvica con el uso de pembrolizumab - ImagenGlobal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Persistencia m\u00e1s progresi\u00f3n locorregional de la enfermedad a c\u00fapula y ganglios il\u00edacos, una posible alternativa a la exenteraci\u00f3n p\u00e9lvica con el uso de pembrolizumab - ImagenGlobal\" \/>\n<meta property=\"og:description\" content=\"Residente de Ginecolog\u00eda y Obstetricia: Isa\u00edas Ram\u00edrez D\u00e1vila, Ginec\u00f3logo Onc\u00f3logo: Jose Miguel Reyes Garita Reporte de caso -Paciente de 35 a\u00f1os. -Sin antecedentes heredo familiares oncolog\u00edcos. -Niega cormobilidades. -Antecedentes Gineco Obst\u00e9tricos. -IVSA: 18 a\u00f1os. -NPS: 1 -PARA: 21011 -CCV OCT 2023 NEGATIVA. Exploraci\u00f3n f\u00edsica Abdomen blando, depresible, no doloroso, sin datos de irritaci\u00f3n peritoneal, vulva&hellip; Leer m\u00e1s\" \/>\n<meta property=\"og:url\" content=\"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/\" \/>\n<meta property=\"og:site_name\" content=\"ImagenGlobal\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-04T07:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-05T04:26:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/imagenglobal.org.mx\/wp-content\/uploads\/2025\/07\/cervix.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/2025\\\/08\\\/04\\\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/2025\\\/08\\\/04\\\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/#\\\/schema\\\/person\\\/f9a554ce4f98a96d314dbb0edccd73f8\"},\"headline\":\"Persistencia m\u00e1s progresi\u00f3n locorregional de la enfermedad a c\u00fapula y ganglios il\u00edacos, una posible alternativa a la exenteraci\u00f3n p\u00e9lvica con el uso de pembrolizumab\",\"datePublished\":\"2025-08-04T07:00:00+00:00\",\"dateModified\":\"2025-08-05T04:26:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/2025\\\/08\\\/04\\\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\\\/\"},\"wordCount\":166,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/2025\\\/08\\\/04\\\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/imagenglobal.org.mx\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cervix.webp\",\"keywords\":[\"COMEGOM\",\"exenteraci\u00f3n p\u00e9lvica\"],\"articleSection\":[\"Art\u00edculos\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/2025\\\/08\\\/04\\\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/2025\\\/08\\\/04\\\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\\\/\",\"url\":\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/2025\\\/08\\\/04\\\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\\\/\",\"name\":\"Persistencia m\u00e1s progresi\u00f3n locorregional de la enfermedad a c\u00fapula y ganglios il\u00edacos, una posible alternativa a la exenteraci\u00f3n p\u00e9lvica con el uso de pembrolizumab - ImagenGlobal\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/2025\\\/08\\\/04\\\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/2025\\\/08\\\/04\\\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/imagenglobal.org.mx\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cervix.webp\",\"datePublished\":\"2025-08-04T07:00:00+00:00\",\"dateModified\":\"2025-08-05T04:26:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/2025\\\/08\\\/04\\\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/2025\\\/08\\\/04\\\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/2025\\\/08\\\/04\\\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\\\/#primaryimage\",\"url\":\"https:\\\/\\\/imagenglobal.org.mx\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cervix.webp\",\"contentUrl\":\"https:\\\/\\\/imagenglobal.org.mx\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cervix.webp\",\"width\":600,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/2025\\\/08\\\/04\\\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/imagenglobal.org.mx\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Persistencia m\u00e1s progresi\u00f3n locorregional de la enfermedad a c\u00fapula y ganglios il\u00edacos, una posible alternativa a la exenteraci\u00f3n p\u00e9lvica con el uso de pembrolizumab\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/#website\",\"url\":\"https:\\\/\\\/imagenglobal.org.mx\\\/\",\"name\":\"ImagenGlobal\",\"description\":\"Imagen Global\",\"publisher\":{\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/imagenglobal.org.mx\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/#organization\",\"name\":\"ImagenGlobal\",\"url\":\"https:\\\/\\\/imagenglobal.org.mx\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/imagenglobal.org.mx\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/LOGO-IG-Trace-White.png\",\"contentUrl\":\"https:\\\/\\\/imagenglobal.org.mx\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/LOGO-IG-Trace-White.png\",\"width\":829,\"height\":842,\"caption\":\"ImagenGlobal\"},\"image\":{\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/imagenglobal.org.mx\\\/#\\\/schema\\\/person\\\/f9a554ce4f98a96d314dbb0edccd73f8\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bba0a366823399c590ad685ce93cc29b12b2b5a68bb3a5cefcd3f8ba6a3c2c95?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bba0a366823399c590ad685ce93cc29b12b2b5a68bb3a5cefcd3f8ba6a3c2c95?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bba0a366823399c590ad685ce93cc29b12b2b5a68bb3a5cefcd3f8ba6a3c2c95?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/imagenglobal.org.mx\"],\"url\":\"https:\\\/\\\/imagenglobal.org.mx\\\/index.php\\\/author\\\/admin_i6njozga\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Persistencia m\u00e1s progresi\u00f3n locorregional de la enfermedad a c\u00fapula y ganglios il\u00edacos, una posible alternativa a la exenteraci\u00f3n p\u00e9lvica con el uso de pembrolizumab - ImagenGlobal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/","og_locale":"es_ES","og_type":"article","og_title":"Persistencia m\u00e1s progresi\u00f3n locorregional de la enfermedad a c\u00fapula y ganglios il\u00edacos, una posible alternativa a la exenteraci\u00f3n p\u00e9lvica con el uso de pembrolizumab - ImagenGlobal","og_description":"Residente de Ginecolog\u00eda y Obstetricia: Isa\u00edas Ram\u00edrez D\u00e1vila, Ginec\u00f3logo Onc\u00f3logo: Jose Miguel Reyes Garita Reporte de caso -Paciente de 35 a\u00f1os. -Sin antecedentes heredo familiares oncolog\u00edcos. -Niega cormobilidades. -Antecedentes Gineco Obst\u00e9tricos. -IVSA: 18 a\u00f1os. -NPS: 1 -PARA: 21011 -CCV OCT 2023 NEGATIVA. Exploraci\u00f3n f\u00edsica Abdomen blando, depresible, no doloroso, sin datos de irritaci\u00f3n peritoneal, vulva&hellip; Leer m\u00e1s","og_url":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/","og_site_name":"ImagenGlobal","article_published_time":"2025-08-04T07:00:00+00:00","article_modified_time":"2025-08-05T04:26:54+00:00","og_image":[{"width":600,"height":400,"url":"https:\/\/imagenglobal.org.mx\/wp-content\/uploads\/2025\/07\/cervix.webp","type":"image\/webp"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admin","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/#article","isPartOf":{"@id":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/"},"author":{"name":"admin","@id":"https:\/\/imagenglobal.org.mx\/#\/schema\/person\/f9a554ce4f98a96d314dbb0edccd73f8"},"headline":"Persistencia m\u00e1s progresi\u00f3n locorregional de la enfermedad a c\u00fapula y ganglios il\u00edacos, una posible alternativa a la exenteraci\u00f3n p\u00e9lvica con el uso de pembrolizumab","datePublished":"2025-08-04T07:00:00+00:00","dateModified":"2025-08-05T04:26:54+00:00","mainEntityOfPage":{"@id":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/"},"wordCount":166,"commentCount":0,"publisher":{"@id":"https:\/\/imagenglobal.org.mx\/#organization"},"image":{"@id":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/#primaryimage"},"thumbnailUrl":"https:\/\/imagenglobal.org.mx\/wp-content\/uploads\/2025\/07\/cervix.webp","keywords":["COMEGOM","exenteraci\u00f3n p\u00e9lvica"],"articleSection":["Art\u00edculos"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/","url":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/","name":"Persistencia m\u00e1s progresi\u00f3n locorregional de la enfermedad a c\u00fapula y ganglios il\u00edacos, una posible alternativa a la exenteraci\u00f3n p\u00e9lvica con el uso de pembrolizumab - ImagenGlobal","isPartOf":{"@id":"https:\/\/imagenglobal.org.mx\/#website"},"primaryImageOfPage":{"@id":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/#primaryimage"},"image":{"@id":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/#primaryimage"},"thumbnailUrl":"https:\/\/imagenglobal.org.mx\/wp-content\/uploads\/2025\/07\/cervix.webp","datePublished":"2025-08-04T07:00:00+00:00","dateModified":"2025-08-05T04:26:54+00:00","breadcrumb":{"@id":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/#primaryimage","url":"https:\/\/imagenglobal.org.mx\/wp-content\/uploads\/2025\/07\/cervix.webp","contentUrl":"https:\/\/imagenglobal.org.mx\/wp-content\/uploads\/2025\/07\/cervix.webp","width":600,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/imagenglobal.org.mx\/index.php\/2025\/08\/04\/persistencia-mas-progresion-locorregional-de-la-enfermedad-a-cupula-y-ganglios-iliacos-una-posible-alternativa-a-la-exenteracion-pelvica-con-el-uso-de-pembrolizumab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/imagenglobal.org.mx\/"},{"@type":"ListItem","position":2,"name":"Persistencia m\u00e1s progresi\u00f3n locorregional de la enfermedad a c\u00fapula y ganglios il\u00edacos, una posible alternativa a la exenteraci\u00f3n p\u00e9lvica con el uso de pembrolizumab"}]},{"@type":"WebSite","@id":"https:\/\/imagenglobal.org.mx\/#website","url":"https:\/\/imagenglobal.org.mx\/","name":"ImagenGlobal","description":"Imagen Global","publisher":{"@id":"https:\/\/imagenglobal.org.mx\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/imagenglobal.org.mx\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/imagenglobal.org.mx\/#organization","name":"ImagenGlobal","url":"https:\/\/imagenglobal.org.mx\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/imagenglobal.org.mx\/#\/schema\/logo\/image\/","url":"https:\/\/imagenglobal.org.mx\/wp-content\/uploads\/2025\/02\/LOGO-IG-Trace-White.png","contentUrl":"https:\/\/imagenglobal.org.mx\/wp-content\/uploads\/2025\/02\/LOGO-IG-Trace-White.png","width":829,"height":842,"caption":"ImagenGlobal"},"image":{"@id":"https:\/\/imagenglobal.org.mx\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/imagenglobal.org.mx\/#\/schema\/person\/f9a554ce4f98a96d314dbb0edccd73f8","name":"admin","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/bba0a366823399c590ad685ce93cc29b12b2b5a68bb3a5cefcd3f8ba6a3c2c95?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bba0a366823399c590ad685ce93cc29b12b2b5a68bb3a5cefcd3f8ba6a3c2c95?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bba0a366823399c590ad685ce93cc29b12b2b5a68bb3a5cefcd3f8ba6a3c2c95?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/imagenglobal.org.mx"],"url":"https:\/\/imagenglobal.org.mx\/index.php\/author\/admin_i6njozga\/"}]}},"jetpack_featured_media_url":"https:\/\/imagenglobal.org.mx\/wp-content\/uploads\/2025\/07\/cervix.webp","_links":{"self":[{"href":"https:\/\/imagenglobal.org.mx\/index.php\/wp-json\/wp\/v2\/posts\/2944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/imagenglobal.org.mx\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/imagenglobal.org.mx\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/imagenglobal.org.mx\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/imagenglobal.org.mx\/index.php\/wp-json\/wp\/v2\/comments?post=2944"}],"version-history":[{"count":3,"href":"https:\/\/imagenglobal.org.mx\/index.php\/wp-json\/wp\/v2\/posts\/2944\/revisions"}],"predecessor-version":[{"id":2952,"href":"https:\/\/imagenglobal.org.mx\/index.php\/wp-json\/wp\/v2\/posts\/2944\/revisions\/2952"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/imagenglobal.org.mx\/index.php\/wp-json\/wp\/v2\/media\/2946"}],"wp:attachment":[{"href":"https:\/\/imagenglobal.org.mx\/index.php\/wp-json\/wp\/v2\/media?parent=2944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/imagenglobal.org.mx\/index.php\/wp-json\/wp\/v2\/categories?post=2944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/imagenglobal.org.mx\/index.php\/wp-json\/wp\/v2\/tags?post=2944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}